Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002444.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -4.56 2.38 2.49
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 52.74 -4.50 -9.53
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.78 12.78 12.43
Cash 11.04 4.93 4.44
Capex 0.55 -0.06 -0.06
Free Cash Flow -83.62 0.09 0.53
Revenue 43.08 2.76 1.93
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.93 0.31 0.32
Operating Margin 63.63 0.14 0.09
ROA 110.91 0.02 < 0.005
ROE 116.92 0.03 0.01
ROIC 148.37 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002444.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002444.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002444.SZ is permitted for members.